Speakers

Loading
Jasmine Ong - Singapore General Hospital

Jasmine Ong

Principal Clinical Pharmacist, Singapore General Hospital
Dr Jasmine Ong is a Critical Care Pharmacist at the Singapore General Hospital, and the SingHealth AI EXCO representing the pharmacists across the cluster and an Adjunct Instructor with the Duke-NUS Medical School, Singapore. She is the first Pharmacist from Singapore who was awarded the US-ASEAN J William Fulbright Scholar to University of California San Francisco, sponsored by the world renowned Professor and Dean of School of Pharmacy Professor Kathy Giacomini; as well as the National Medical Research Council (NMRC) Clinician Innovator Award. She received her Doctor of Pharmacy (PharmD) degree in 2018 from the National University of Singapore and board certification in critical care pharmacy (BCCCP, USA) in 2020. Her research interests include pharmacokinetics / pharmacodynamics of adult critically ill patients, as well as artificial intelligence and health technology innovation. To date, she is a PI managing >2.5M research grants, spearheading the AI work on medication safety, smart medication devices technology in collaboration with different institute of higher learnings in Singapore, such as IHIS, A*STAR and National University of Singapore. Moreover, she is a co-investigator in various multi-center local studies including BLAST (Beta-Lactam TDM in Singapore), SingXaD (Singapore Study of DOAC Anti-Xa levels) as well as international trials such as RE-ENERGIZE (Glutamine supplementation in burns injured patients). She has published in several high impact factor journals including the Lancet Digital Heath, NEJM AI and Nature Medicine, and won accolades such as the SingHealth Young Discoverer Award (Allied Health) in recognition of her research and innovation pursuits. Jasmine is also an active core member of several international committees such as CARE-AI (Collaborative Assessment for Responsible and Ethical AI Implementation) and POLARIS-GM (Partnership for Oversight, Leadership and Accountability in Regulating Intelligent Systems – Generative Models in Medicine).
Sessions